| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8485568 | Vaccine | 2018 | 7 Pages |
Abstract
In conclusion, the vaccine strain O1/BFS is likely to confer protection against 89% of the 45 FMDV/O isolates based on VNT. Thus O1/BFS vaccine strain is still suitable for use in global FMD serotype O outbreak control. Combining data from phylogenetic, molecular and antigenic analysis can provide improvements in the process of vaccine selection.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Wanhong Xu, Zhidong Zhang, Charles Nfon, Ming Yang,